Potassium paraaminobenzoate vs placebo
Patient‐reported ability to have intercourse · men with acute (maximum of 12 months) Peyronie's disease with no prior treatment and no evidence of calcified plaques (pain during…
Potassium paraaminobenzoate showed no clear difference in patient‐reported ability to have intercourse compared with placebo (low certainty).
1 finding from 1 review
- RR 1.19 [0.87, 1.62]1 study · 75 participantsLow